Beginner's Mind-logo

Beginner's Mind

Business & Economics Podcasts

Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Leave your eMail -

Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Leave your eMail -




Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Leave your eMail -








#32: Tax & Funding Update 2021 - Tech in Austria – Ask the Tax Experts of KPMG Austria

A new year brings new tax rules. Astrid Woollard and Christian Soschner asked the Tax Experts of KPMG Austria to give an update on the newest regulations in Austria. We also had a chance to talk about tax advisors and auditors' roles in the start-up economy. Listen to this episode to learn what's new and when to consult advisors. If you have questions after listening to the episode, reach out to Michael and Oliver. For the videophile: The Video to the Podcast Resources mentioned in...


#31: This was 2020 - A Year in Review

What was hot and what not - in Blockchain and Life Science and other Tech Areas the speakers love. Listen about what was going on in the world in 2020 - besides SARS CoV 2. Speaker: Albert Missbichler ( Astrid Woollard ( Christian Soschner ( Elisabeth Pfneisl ( Gregory Mannix...


#30: How to Patent Digital Business Models

At the beginning of the new millennium, the next technological quantum leap began to emerge, known as the fourth industrial revolution – or Industry 4.0 for short. New technologies permit the development of new business models. In general, a business model describes a company’s business processes to achieve a defined business objective within the context of its social environment. The term sums up visions, ideas, defining features, and design models. In the context of digitization,...


#29: Ultraleap. Digital Worlds that Feel Human.

One problem in the digital world is: We cannot feel the interaction. Prof. Sriram Subramanian is working on solutions for this problem. He has spun out Ultraleap from the University of Bristol. The company translates the research into products for the digital world. In this episode, I will talk with Prof. Subramanian about real-life applications for his inventions, the importance of touch for well-being, and the potential for the life science industry. Speaker: Christian Soschner...


#28: How to Close a 20 million CHF Series B Round During a Pandemic

Let's sit down for a conversation about my favorite topic: Fundraising in the Life Science Industry. How is it to raise significant financing rounds during a pandemic when the research focus is not related to SARS-CoV-2? It is my pleasure to welcome Dr. Daniela Marino, CEO and Co-founder of Cutiss AG. Speaker: Christian Soschner ( Daniela Marino ( Organizations: CS Life Science Invest...


#27: How to Find Your Vision and Passion for Founding a Company

In the last episodes, I have talked with investors and decision-makers of the pharmaceutical industry about the importance of having a vision and passion for the life science company. I want to explore this topic further and ask the life science entrepreneur Christof Goetz to chat with me about finding your vision and passion for your company. Christof is a Serial Entrepreneur with more than 20 years of experience managing complex business, software, and hardware development...


#26: Science Explained - PCR Tests for Dummies

In this episode, I had the pleasure of talking with two Diagnostics Experts. Irina Korschinek, CEO of Ingenetix and Albert Missbichler, Business Angel specialized in Diagnostics. Do you want to know answers to all or one of the following questions? • What is a PCR test? • Why is it the gold standard for measuring SARS-Cov2 Infections? • What does a positive or negative test result say? • Why do false positives and false negatives exist. Shouldn`t the test have 100% accuracy? • Why do...


#25: What Is the Secret to Successful Tech Transfer?

Did you know that the successful pipeline of one of the most important pharmaceutical companies in the United States started in Europe, and scientists from Prague played a key role? Did you know that profound expertise in turning deep tech life science into a business, scale it, and go public in the US can be found in Prague since the late 80s of the previous century? If you want to know which US pharmaceutical companies pipeline started in Prague, then listen to this Episode Number 25. I...


#24: How Young Scientist Are Trained Towards Entrepreneurship in Oxford

Listen to my inspiring conversation with Vassilis Ragoussis about initiatives that support young scientists to become Entrepreneurs. We dived deep into the entrepreneurial Life Science Eco-System in Oxford, Europe, and the United States. If you want to know what the Eco-System in Oxford is doing for young scientist entrepreneurs, this podcast is for you. Learn more about Oxford University Biotech Society and Oxford Foundry. Vassilis is an avid networker and a Ph.D. student at the...


#23: How Is Life These Days for Early-Stage Investors in Europe?

Listen to my conversation with Nicolaj Højer Nielsen about the life of an early-stage investors in Europe. Nicolaj Højer Nielsen is a serial entrepreneur and business angel who has been building startups since 1999. He focuses on high potential startups and has co-founded and invested in thirteen companies, primarily within IT. He has experience securing funding from all possible sources – friends and family, business angels, VC funds, and public funds. His expertise is based on reviewing...


#22: How Is China Managing the Coronavirus Situation in 2020?

We are in the 7th month of the SARS-CoV-2 Pandemic in Europe. Governments are doing what’s necessary to deal with the situation. More and more governments are initiating strong measures to control the infection rate with SARS-CoV-2. Israel has announced a second lockdown from September 18 for about three weeks. There is a lot of coverage of European measures in the local news. Also, a lot of information is published about actions taken in the United States. I rarely read anything about...


#21: How to Partner with Big Pharma?

Do you want to know how to approach Pharma? Do you want to learn what information is needed to partner a life science project with Pharma? And how long the process takes? Then this podcast is for you. Listen to the expertise of Natalia Novac, Director of Emerging Technologies and Innovation, Eli Lilly. Natalia has profound experience in strategy, corporate, and business development. She had leading roles at Merck and now Eli Lilly. Speaker: Christian Soschner...


#20: How to close a 40 million Euro financing round in less than 8 weeks

In light of the pandemic, the Life Science Industry is changing. One of the positive developments: The industry is moving faster. The necessity of developing diagnostics, therapeutics, and vaccines against this novel viral threat quickly generates a steep learning curve for all of us. In this episode, I am talking with Peter Llewellyn-Davies, CEO of Apeiron Biologics, how he and his team have set up a clinical phase 2 trial and a 40 million Euro financing round in less than eight...


#19: Life Science - the Investors Perspective

Since the beginning of the SARS-CoV-2 Pandemic, more and more people got interested in the Life Science Industry. Scientists worldwide have worked together for decades and centuries to solve the world's most severe health problems. In the last decades, a unique Eco-System of start-ups, investors, industrial partners, and public funding organizations evolved out of this search for finding cures against the world's most complex diseases. In this episode, you will hear: How important is...


#18: The Secrets of Life Science Business Models

Rumour has it: It takes 10-15 years to bring a new therapy to the patients. Only 1% of all scientific ideas make it to the market - is another statistical fact. How do those people who made developing novel therapies their mission make money on their way? In this episode, I have the huge pleasure to chat with Thomas Schirrmann. He has profound experience in starting companies from scratch, walking through the ups and downs of Death Valley, and turn it into a commercial success. Listen to...


#17 How to found a Life Science Company in the US

How is it to start a company from scratch, found it and fund it in the US, and get customers like the US Air Force and the Department of Defence. In this episode, you will hear how Jessica Walsh, Founder, and CEO of RxBandz, one of the most successful women in life science in the world, did it. In this episode, listen to Jessica’s stories about how to get into life science out of necessity, how it is to find the right team and develop the team and the project at the same...


#16 How to Network Strategically

We are the average of the five people we spent the most time with. Or are we the opposite? Listen in this podcast episode how Daria Tataj sees it. Daria is THE number one networking expert in Europe. Daria Tataj is a researcher, Ph.D., keynote speaker, author, and world expert on innovation networks. After having reached more than 30.000 decision-makers around the world through her work helping companies, governments, and cities to foster innovation through the strategic use of...


#15: LSG2G #12 - How to Invest in Life Science

Everybody comes in touch with the life science industry. Hardly anybody knew about the challenges, and hardships scientists have to overcome to bring a product from the university-level to the market. Since the outbreak of SARS-CoV-2, more and more people are becoming interested in life science investments. And ask the question: How does that work? In this episode, I am talking with entrepreneurs and investors from the LSG2G network. How do life science investments work? What are investors...


#14: IECT Summer School

The current pandemic shines a light on deep tech companies. Especially in life science. Did you ask yourself the question: What is necessary to bring a scientific idea from universities into companies and ultimately onto the market? In this episode, I am talking with Klara Brandstätter and Jasmin Gungör. They are responsible for training, financing, and connecting deep-tech scientists. What exactly they are doing, you will hear in this episode. Speaker: Christian Soschner...


#13: European Grant Funding - with Crowdhelix and UCL

How to bring scientific life science ideas to patients? Three key components are needed: 1. World-class science 2. World-class development team 3. Massive public and private funding In this episode, I am talking with Michael Browne and Kimberly Cornfield on how to solve these three problems. Reach out to Kimberly and Michael if you want to access their top-notch science networks within Crowdhelix and UCL. Speaker: Christian Soschner...